Tricyclic therapy of the DSM-III anxiety disorders

A review with implications for further research

Michael R. Liebowitz, Abby J. Fyer, Jack M. Gorman, Raphael B. Campeas, Diana P. Sandberg, Eric Hollander, Lazlo A. Papp, Donald F. Klein

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Existing data suggests dramatic efficacy for all tested tricyclics in disorders involving spontaneous panic attacks; moderate efficacy for clomipramine but not other tricyclics in obsessive-compulsive patients; possible, but as yet not well established, tricyclic efficacy in generalized anxiety; and lack of efficacy in simple phobias. Further studies in all DSM-III Anxiety Disorders are both warranted and required to answer the nonological, pathophysiological and treatment questions raised by these findings.

Original languageEnglish (US)
Pages (from-to)7-31
Number of pages25
JournalJournal of Psychiatric Research
Volume22
Issue numberSUPPL. 1
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Clomipramine
Panic Disorder
Anxiety Disorders
Diagnostic and Statistical Manual of Mental Disorders
Anxiety
Research
Therapeutics
Specific Phobia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Psychology(all)

Cite this

Liebowitz, M. R., Fyer, A. J., Gorman, J. M., Campeas, R. B., Sandberg, D. P., Hollander, E., ... Klein, D. F. (1988). Tricyclic therapy of the DSM-III anxiety disorders: A review with implications for further research. Journal of Psychiatric Research, 22(SUPPL. 1), 7-31. https://doi.org/10.1016/0022-3956(88)90067-2

Tricyclic therapy of the DSM-III anxiety disorders : A review with implications for further research. / Liebowitz, Michael R.; Fyer, Abby J.; Gorman, Jack M.; Campeas, Raphael B.; Sandberg, Diana P.; Hollander, Eric; Papp, Lazlo A.; Klein, Donald F.

In: Journal of Psychiatric Research, Vol. 22, No. SUPPL. 1, 1988, p. 7-31.

Research output: Contribution to journalArticle

Liebowitz, MR, Fyer, AJ, Gorman, JM, Campeas, RB, Sandberg, DP, Hollander, E, Papp, LA & Klein, DF 1988, 'Tricyclic therapy of the DSM-III anxiety disorders: A review with implications for further research', Journal of Psychiatric Research, vol. 22, no. SUPPL. 1, pp. 7-31. https://doi.org/10.1016/0022-3956(88)90067-2
Liebowitz, Michael R. ; Fyer, Abby J. ; Gorman, Jack M. ; Campeas, Raphael B. ; Sandberg, Diana P. ; Hollander, Eric ; Papp, Lazlo A. ; Klein, Donald F. / Tricyclic therapy of the DSM-III anxiety disorders : A review with implications for further research. In: Journal of Psychiatric Research. 1988 ; Vol. 22, No. SUPPL. 1. pp. 7-31.
@article{d9c7210f672645dca9e2d36180ce6c29,
title = "Tricyclic therapy of the DSM-III anxiety disorders: A review with implications for further research",
abstract = "Existing data suggests dramatic efficacy for all tested tricyclics in disorders involving spontaneous panic attacks; moderate efficacy for clomipramine but not other tricyclics in obsessive-compulsive patients; possible, but as yet not well established, tricyclic efficacy in generalized anxiety; and lack of efficacy in simple phobias. Further studies in all DSM-III Anxiety Disorders are both warranted and required to answer the nonological, pathophysiological and treatment questions raised by these findings.",
author = "Liebowitz, {Michael R.} and Fyer, {Abby J.} and Gorman, {Jack M.} and Campeas, {Raphael B.} and Sandberg, {Diana P.} and Eric Hollander and Papp, {Lazlo A.} and Klein, {Donald F.}",
year = "1988",
doi = "10.1016/0022-3956(88)90067-2",
language = "English (US)",
volume = "22",
pages = "7--31",
journal = "Journal of Psychiatric Research",
issn = "0022-3956",
publisher = "Elsevier Limited",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Tricyclic therapy of the DSM-III anxiety disorders

T2 - A review with implications for further research

AU - Liebowitz, Michael R.

AU - Fyer, Abby J.

AU - Gorman, Jack M.

AU - Campeas, Raphael B.

AU - Sandberg, Diana P.

AU - Hollander, Eric

AU - Papp, Lazlo A.

AU - Klein, Donald F.

PY - 1988

Y1 - 1988

N2 - Existing data suggests dramatic efficacy for all tested tricyclics in disorders involving spontaneous panic attacks; moderate efficacy for clomipramine but not other tricyclics in obsessive-compulsive patients; possible, but as yet not well established, tricyclic efficacy in generalized anxiety; and lack of efficacy in simple phobias. Further studies in all DSM-III Anxiety Disorders are both warranted and required to answer the nonological, pathophysiological and treatment questions raised by these findings.

AB - Existing data suggests dramatic efficacy for all tested tricyclics in disorders involving spontaneous panic attacks; moderate efficacy for clomipramine but not other tricyclics in obsessive-compulsive patients; possible, but as yet not well established, tricyclic efficacy in generalized anxiety; and lack of efficacy in simple phobias. Further studies in all DSM-III Anxiety Disorders are both warranted and required to answer the nonological, pathophysiological and treatment questions raised by these findings.

UR - http://www.scopus.com/inward/record.url?scp=0023693477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023693477&partnerID=8YFLogxK

U2 - 10.1016/0022-3956(88)90067-2

DO - 10.1016/0022-3956(88)90067-2

M3 - Article

VL - 22

SP - 7

EP - 31

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

SN - 0022-3956

IS - SUPPL. 1

ER -